Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
about
Prebiotics in infants for prevention of allergyRole of cellular immunity in cow's milk allergy: pathogenesis, tolerance induction, and beyondAssociation between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review.Food allergy and food-based therapies in neurodevelopmental disorders.Prebiotics in infant formula.Oligosaccharides in infant formula: more evidence to validate the role of prebiotics.In Vitro Evidence for Immune-Modulatory Properties of Non-Digestible Oligosaccharides: Direct Effect on Human Monocyte Derived Dendritic CellsScientific evidence for health effects attributed to the consumption of probiotics and prebiotics: an update for current perspectives and future challenges.A pilot study on the application of a symptom-based score for the diagnosis of cow's milk protein allergy.Discovering the link between nutrition and skin aging.Probiotics and prebiotics in infants and children.Serum biomarkers for allergy in children.Contributions of the intestinal microbiome in lung immunity.Immunological properties of inulin-type fructans.Meta-analysis of probiotics and/or prebiotics for the prevention of eczema.Effect of Dietary Fiber and Metabolites on Mast Cell Activation and Mast Cell-Associated Diseases.
P2860
Q24199115-134EC3F1-AE56-44C8-A32A-FE8061F4F904Q33804933-53AE72A9-A0DC-4B64-8787-97B62AC58DFCQ35039235-B53B0854-1161-4C7D-9119-69A1B727A7EDQ35044148-3DC578EC-DD48-4559-8AB4-FC7CFC8EDBEEQ35533104-048E1380-5D89-4E62-8E91-B2A6915AAACEQ35635413-23BF7C17-3A09-4A81-9A5E-4E40309CBD8CQ35684219-0CC9844E-52D8-4310-B27A-C2E01968F2FCQ35800667-C0487D98-88B4-4BAB-BBDC-F30174C8BFB8Q36165767-075BB786-7492-43BE-BFDB-6EA3E1695C57Q36643595-EB9729BA-F486-4B72-8A67-430D1B41DAA4Q38103761-E5EE6A7C-3F12-4093-A1EF-41C7CE9B7D8AQ38945312-55E3DEDE-26DE-4C26-8C06-74CE8A026AA5Q40106773-F9AB59B6-E08E-454F-B2C7-C7D53C3F9D82Q44527892-A88BA992-BB03-4D5B-A443-FB796A81FF7CQ45213834-9836B9F0-66A4-4766-9834-C8D005B61B35Q55079819-AAB27A7D-E43F-4ADF-BCA4-68CC20EDCE05
P2860
Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@en
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@nl
type
label
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@en
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@nl
prefLabel
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@en
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@nl
P2093
P2860
P1476
Non-digestible oligosaccharide ...... n infants at risk for allergy.
@en
P2093
Bastiaan Schouten
Betty C A M Van Esch
Frank A Redegeld
Guido E Moro
Günther Boehm
Johan Garssen
Linette E M Willemsen
Léon M J Knippels
Sertac Arslanoglu
Tom G Kormelink
P2860
P304
P356
10.1111/J.1399-3038.2010.01132.X
P577
2011-08-01T00:00:00Z